References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Christensenetal(2007)CytoreductiveantitumoractivityofPF-2341066,anovelinhibitorofanaplasticlymphomakinaseandc-Met,inexperimentalmodelsofanaplasticlarge-celllymphoma.Mol.CancerTher.63314PMID:18089725
Zouetal(2007)Anorallyavailablesmall-moleculeinhibitorofc-Met,PF-2341066,exhibitscytoreductiveantitumorefficacythroughantiproliferativeandantiangiogenicmechanisms.CancerRes.674408PMID:17483355
Cuietal(2011)Structurebaseddrugdesignofcrizotinib(PF-02341066),apotentandselectivedualinhibitorofmesenchymal-epithelialtransitionfactor(c-MET)kinaseandanaplasticlymphomakinase(ALK).J.Med.Chem.546342PMID:21812414
Keywords:Crizotinib,supplier,c-MET,alk,anaplastic,lymphoma,kinases,antitumor,selective,potent,PF2341066,PF02341066,PF,02341066,PF,2341066,MET,Receptors,ALK,ALK,TocrisBioscience